Development of Bicyclo[3.1.0]hexane-Based A3 Receptor Ligands: Closing the Gaps in the Structure-Affinity Relationships

Molecules. 2022 Mar 31;27(7):2283. doi: 10.3390/molecules27072283.

Abstract

The adenosine A3 receptor is a promising target for treating and diagnosing inflammation and cancer. In this paper, a series of bicyclo[3.1.0]hexane-based nucleosides was synthesized and evaluated for their P1 receptor affinities in radioligand binding studies. The study focused on modifications at 1-, 2-, and 6-positions of the purine ring and variations of the 5'-position at the bicyclo[3.1.0]hexane moiety, closing existing gaps in the structure-affinity relationships. The most potent derivative 30 displayed moderate A3AR affinity (Ki of 0.38 μM) and high A3R selectivity. A subset of compounds varied at 5'-position was further evaluated in functional P2Y1R assays, displaying no off-target activity.

Keywords: A3 receptors; Adenosine receptors; bicyclo[3.1.0]hexane; methanocarba.

MeSH terms

  • Animals
  • CHO Cells
  • Cricetinae
  • Hexanes*
  • Ligands
  • Nucleosides / chemistry
  • Radioligand Assay
  • Receptor, Adenosine A3* / chemistry
  • Structure-Activity Relationship

Substances

  • Hexanes
  • Ligands
  • Nucleosides
  • Receptor, Adenosine A3